LIVN LivaNova
- 59.660
- -0.910-1.50%
LivaNova News
LivaNova to Present at the Goldman Sachs Healthcare Conference
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs Healthcare Conference in Miami,
Calculating The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Key Insights The projected fair value for LivaNova is US$78.84 based on 2 Stage Free Cash Flow to Equity With US$64.15 share price, LivaNova appears to be trading close to its estimated fair value
LivaNova First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)
LivaNova Price Target Raised to $80.00/Share From $75.00 by Mizuho
LivaNova Price Target Raised to $80.00/Share From $75.00 by Mizuho
LivaNova Is Maintained at Neutral by Baird
LivaNova Is Maintained at Neutral by Baird
Baird: Maintaining the LivaNova (LIVN.US) rating, adjusted from neutral to neutral, and adjusted the target price from $58.00 to $66.00.
Baird: Maintaining the LivaNova (LIVN.US) rating, adjusted from neutral to neutral, and adjusted the target price from $58.00 to $66.00.
Baird Maintains Neutral on LivaNova, Raises Price Target to $66
Baird analyst Mike Polark maintains LivaNova (NASDAQ:LIVN) with a Neutral and raises the price target from $58 to $66.
LivaNova Price Target Maintained With a $72.00/Share by Needham
LivaNova Price Target Maintained With a $72.00/Share by Needham
Needham: Reiterates the LivaNova (LIVN.US) rating and adjusted from buy to buy rating, target price is $72.00.
Needham: Reiterates the LivaNova (LIVN.US) rating and adjusted from buy to buy rating, target price is $72.00.
Needham Reiterates Buy on LivaNova, Maintains $72 Price Target
Needham analyst Mike Matson reiterates LivaNova (NASDAQ:LIVN) with a Buy and maintains $72 price target.
LivaNova Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 16.5% Needham → $72 Reiterates Buy → Buy 03/27/2024 21.36% Mizuho $75 → $75 Maintains Buy 03/20
LivaNova: Strong Buy Rating Backed by Robust Growth and Positive Outlook
Express News | Jefferies raised Livanova's price target from $82 to $90.
Earnings Call Summary | LivaNova(LIVN.US) Q1 2024 Earnings Conference
The following is a summary of the LivaNova PLC (LIVN) Q1 2024 Earnings Call Transcript:Financial Performance:LivaNova reported Q1 revenue growth of 12%, 14% if excluding the wind down of the ACS segme
LivaNova Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised FY24 Guidance.
LivaNova Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised FY24 Guidance.
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining over 50 points on Wednesday.Shares of Powell Industries, Inc. (NASDAQ:POWL) rose sharply during Wednesday's session after the company reported
LivaNova PLC (LIVN) Surpasses Analyst Revenue Forecasts in Q1 2024
Earnings Flash (LIVN) LIVANOVA Reports Q1 Revenue $294.9M, Vs. Street Est of $278.2M
06:15 AM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (LIVN) LIVANOVA Reports Q1 Revenue $294.9M, vs. Street Est of $278.2M
LivaNova Beats Top-line and Bottom-line Estimates; Raises FY24 Outlook
Analysis
Price Target
No Data
